INDIANAPOLIS, March 15 /PRNewswire/ -- Vertellus Specialties Inc., a leading specialty chemicals company, today announced plans to expand significantly its manufacturing capacity of Vitride(R) reducing agent in response to growing worldwide demand. This increased manufacturing capacity is scheduled to be operational in June 2010 through an expedited development project conducted at the Company's Vitride(R) manufacturing facility in Zeeland, Michigan. These efforts represent a steady and ongoing commitment to Vertellus' longstanding leadership position in Vitride(R) manufacture.
Dr. Jim Keay, Business Director for Vertellus Specialty Chemicals division, says, "We continue to see good opportunities to improve customers' processes using Vitride(R) as well as helping generic pharmaceutical producers find more manageable routes to their new products. Often companies working on complex molecule development programs encounter challenges in the reduction step. With our experience in working on reactions of this type, we can provide support and guidance to improve the selectivity, yield and overall cost of the target molecule."
About Vertellus Specialties Inc.
Vertellus is a specialty chemicals company focused on the manufacture of ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and a host of other market areas affected by trends favoring "green" technologies and chemistries. Vertellus is the #1 global producer of pyridine and picolines, specialty pyridine derivatives, DEET, castor oil derivatives and systems, and citrate polymer additives and systems, and the world's #2 producer of Vitamin B-3. Vertellus benefits from a technically advanced global manufacturing base and has approximately 750 employees. Vertellus is headquartered in Indianapolis, Indiana. For more information, visit www.vertellus.com.
Vertellus Specialties Inc.
